The U.S. cannabis industry continues expanding, creating opportunities for ancillary companies that support cultivation and retail operations the U.S. legal cannabis industry experienced significant growth, with sales reaching approximately $31.4 billion, marking a 9.14% increase from the previous year. Industry experts predict sales could reach $50 billion by 2028 as more states legalize marijuana. Recently, Congress discussed federal cannabis reform, increasing speculation about potential rescheduling. If federal legalization advances, ancillary stocks could see strong momentum. These companies provide essential products, including hydroponics, lighting, and packaging, benefiting from growing cannabis demand. As the industry evolves, investors are closely watching top-performing ancillary stocks this week.

To navigate cannabis stocks, investors should use technical analysis and risk management strategies. Identifying key support and resistance levels helps time entries and exits efficiently. Volume trends and moving averages also provide insight into stock momentum. Additionally, diversifying investments reduces risk in this volatile sector. As legalization efforts progress, tracking market sentiment and sector news remains essential.

Key Players in the Industry

The cannabis industry continues to expand in the U.S., creating strong demand for ancillary companies. These companies provide essential products and services to cannabis cultivators and dispensaries. With legalization efforts gaining traction, ancillary stocks could see significant growth in 2025.

This month, three top ancillary cannabis stocks stand out. GrowGeneration Corp. (GRWG) specializes in hydroponic and organic gardening products. Hydrofarm Holdings Group, Inc. (HYFM) supplies lighting, ventilation, and nutrients to cannabis growers. Scotts Miracle-Gro Company (SMG) dominates the lawn and garden market while expanding its cannabis-focused division. Each of these companies plays a vital role in the industry’s supply chain.

Investors should consider these stocks due to their strong market presence and financial performance. Let’s take a closer look at what makes each of them a top pick in March 2025.

[Read More]  3 Canadian Marijuana Stocks To Watch For Future Gains 2025

March 2025’s Top Ancillary Cannabis Stocks: Companies Powering the Green Industry

1. GrowGeneration Corp. (NASDAQ: GRWG)
2. Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM)
3. Scotts Miracle-Gro Company (NYSE: SMG)

GrowGeneration Corp. (GRWG)

GrowGeneration Corp. (GRWG) is the largest hydroponics and specialty gardening retailer in the U.S. The company operates over 60 retail locations nationwide, supplying cannabis cultivators with nutrients, lighting, and grow tents. It has a strong presence in key cannabis markets, including California, Colorado, and Michigan. These states have established recreational and medical cannabis programs, making them critical to GrowGeneration’s success.

The company also sells its products online through its e-commerce platform. This has allowed it to reach customers beyond its physical locations. GrowGeneration continues to expand by acquiring smaller hydroponics companies and opening new stores in emerging markets. Its strong distribution network gives it an edge over competitors.

Financially, GrowGeneration has maintained stable revenue despite industry challenges. In its latest earnings report, the company reported $260 million in annual revenue. While this is a slight decline from previous years, cost-cutting measures have helped improve profitability.

Gross margins have remained strong at around 28%, showing efficient operations. The company has reduced operating expenses and streamlined its supply chain. These actions have helped maintain positive cash flow. Additionally, GrowGeneration’s e-commerce sales continue to grow, contributing to overall revenue stability.

Looking ahead, the company plans to focus on higher-margin products. It also aims to expand into new markets as more states legalize cannabis. With improving financials and strategic expansion, GrowGeneration remains a key ancillary stock to watch in 2025.

[Read More]  March 2025’s Top Cannabis Stocks: Key Players in the Growing Market

Hydrofarm Holdings Group, Inc. (HYFM)

Hydrofarm Holdings Group, Inc. (HYFM) is a leading supplier of hydroponic equipment and agricultural technology. The company provides lighting, climate control systems, and nutrients for indoor cannabis cultivation. It operates multiple distribution centers across North America, ensuring efficient delivery of products.

Hydrofarm’s largest presence is in the United States, where it serves commercial and home growers. The company’s products are widely used in California, Oregon, and Washington. These states have a strong cannabis cultivation industry, making them key markets for Hydrofarm.

The company has expanded its product portfolio through acquisitions of leading hydroponics brands, strengthening its position in the cannabis industry. It also continues to invest in research and development to improve its products.

Financially, Hydrofarm has faced challenges in recent years. However, its latest earnings report showed signs of recovery. The company reported $350 million in revenue, marking a 10% increase from the previous year. Cost reductions and supply chain improvements have contributed to better margins.

Despite previous losses, Hydrofarm has improved its cash flow and reduced debt. This financial discipline is helping the company stabilize its operations. The demand for hydroponic solutions remains high as cannabis cultivation expands.

Looking forward, Hydrofarm plans to introduce new energy-efficient lighting solutions. These innovations aim to reduce growers’ cultivation costs. The company also expects further growth from its commercial partnerships. Hydrofarm could see stronger financial performance in 2025 if the industry continues expanding.

[Read More]  3 Top Marijuana Stocks for Better Trading After Earnings

Scotts Miracle-Gro Company (SMG)

Scotts Miracle-Gro Company (SMG) is a lawn and garden care household name. While known for traditional gardening products, it has built a strong presence in the cannabis industry. Through its subsidiary, Hawthorne Gardening Company, Scotts provides lighting, fertilizers, and hydroponic systems for cannabis growers.

The company operates nationwide, with a significant presence in states like California, Colorado, and Michigan. Both home and commercial cannabis cultivators widely use its products. Hawthorne Gardening has become a market leader in hydroponic solutions, making Scotts a major ancillary cannabis stock.

In addition to its hydroponic business, Scotts continues expanding its organic and environmentally friendly product lines. This strategy aligns with increasing consumer demand for sustainable cultivation practices.

Financially, Scotts Miracle-Gro has maintained steady revenue growth. In its latest report, the company announced $4.2 billion in annual sales. This represents a slight increase from the previous year, driven by its Hawthorne division.

However, rising production costs have impacted overall profit margins. Scotts has responded by optimizing operations and streamlining product distribution. Despite economic challenges, it remains profitable, with strong cash reserves.

The company also continues to return value to shareholders through dividends and stock buybacks. Its diversified product portfolio provides stability in fluctuating markets. With continued investment in the cannabis sector, Scotts Miracle-Gro remains a strong pick for ancillary cannabis investors in 2025.

[Read More]  Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Must-Watch Ancillary Cannabis Stocks for Smart Investors

Ancillary cannabis stocks not only provide essential products and services to the growing cannabis industry but also play a vital role in its expansion. Companies like GrowGeneration, Hydrofarm, and Scotts Miracle-Gro have not only positioned themselves as industry leaders but have also built strong market presence. Because of this, their dominance in key U.S. cannabis markets makes them attractive investment options.

Even though the industry faces challenges, these companies continue to adapt by focusing on financial improvements, strategic expansions, and new product developments. As a result, their growth remains strong. Investors seeking exposure to the cannabis sector without directly investing in cultivation should seriously consider these ancillary stocks.

Furthermore, with increasing legalization and rising demand for cultivation products, these companies are set to benefit in 2025. Therefore, keeping an eye on their financial performance and market trends will help investors make informed decisions. Ultimately, as the cannabis industry evolves, ancillary stocks will remain crucial to its success.

The post March 2025 Watchlist: Top Ancillary Cannabis Stocks Poised for Growth appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, creating opportunities for investors. In 2024, legal cannabis sales surpassed $30 billion, and analysts expect growth to reach $40 billion by 2025. Several states are pushing for new legalization measures, which could drive more revenue into the sector. Recently, lawmakers have discussed potential federal cannabis reform, including banking access and decriminalization efforts. This news has sparked renewed interest in marijuana penny stocks, which often see high volatility. These low-priced stocks can deliver significant gains but also have higher risks.

Investors should use technical analysis to identify potential entry points before making decisions. Support and resistance levels, moving averages, and trading volume can help confirm price trends. Proper risk management is also essential when trading volatile stocks. Setting stop-loss orders and managing position sizes can help limit losses. As market conditions shift, these penny stocks may offer opportunities for short-term gains in the cannabis sector.

The cannabis industry continues to show resilience despite recent market fluctuations. Many investors are watching for potential growth as legalization efforts progress. The U.S. cannabis market is projected to reach $40 billion by 2025, making it an attractive sector. Companies with strong market positions and expanding operations could see significant gains in the coming months.

This article highlights three top marijuana stocks to watch in March 2025. These companies have notable footprints in the U.S. cannabis industry. They also have strong financials that suggest growth potential. Here’s a closer look at Planet 13 Holdings Inc. (PLNHF), Glass House Brands Inc. (GLASF), and Cresco Labs Inc. (CRLBF).

[Read More] 3 Top Marijuana For Better Trading After Earnings

Top 3 Marijuana Stocks to Watch in March 2025

1. Planet 13 Holdings Inc. (OTC: PLNHF)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNHF)

Planet 13 Holdings Inc. is a well-known cannabis company focusing on superstore dispensaries. It operates some of the largest cannabis retail locations in the U.S. The company is best known for its Las Vegas Superstore, a massive dispensary with an immersive shopping experience.

Besides its flagship location, Planet 13 has expanded to California and Florida. In California, it operates a large dispensary in Santa Ana. The company is also developing additional stores in other high-traffic locations. With plans to expand further, Planet 13 aims to be a leader in the premium cannabis retail market.

Latest Financial Performance

Planet 13 reported strong revenue growth in its latest earnings report. In the most recent quarter, revenue reached $28.5 million, marking an increase from the previous year. This growth was driven by higher foot traffic and increased product offerings.

The company’s gross profit margin improved as well, reaching 50%. This was due to better cost management and strong sales of in-house brands. However, operating expenses remained high due to expansion efforts. Planet 13 continues investing in new locations to strengthen its market position.

Additionally, the company maintains a strong cash position. It holds over $45 million in cash and equivalents, which supports future growth plans. With a focus on innovation and customer experience, Planet 13 remains a stock to watch in the cannabis sector.

[Read More] Top Marijuana Stocks For Investors In The Cannabis Space

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is one of the largest vertically integrated cannabis operators in California. The company focuses on cultivation, processing, and retail sales. It owns and operates several high-tech greenhouses, producing premium cannabis at low costs.

Glass House’s largest cultivation facility is located in Santa Barbara, California. This greenhouse spans over 5.5 million square feet, making it one of the biggest in the U.S. The company also operates multiple dispensaries, including The Pottery and Farmacy locations. Glass House aims to expand further in California, focusing on low-cost production and high-quality products.

Latest Financial Performance

Glass House Brands recently reported record revenue growth. The company generated $50.2 million in quarterly revenue, representing a 45% year-over-year increase. This growth was fueled by higher production capacity and increasing retail sales.

The company’s gross profit margin also improved, reaching 38%. This was due to its low-cost cultivation strategy, which helps maintain strong profit margins. However, Glass House reported a net loss of $5.2 million, mainly due to expansion costs.

Despite the loss, Glass House remains financially strong. It holds $30 million in cash, providing flexibility for future investments. With its cost-efficient cultivation model, the company is well-positioned for long-term growth. Investors looking for exposure to the California market should keep an eye on this stock.

[Read More]  Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. is one of the largest multi-state cannabis operators (MSOs) in the U.S. The company focuses on both retail and wholesale cannabis sales, supplying dispensaries across multiple states. It operates under the Sunnyside brand, which has a strong presence in key markets.

Cresco has over 70 dispensaries in the U.S., with major operations in Illinois, Pennsylvania, and Florida. Illinois remains its largest market, benefiting from strong adult-use sales. The company also owns several cultivation and processing facilities, allowing it to control production costs. With ongoing expansion, Cresco continues to strengthen its market position.

Latest Financial Performance

Cresco Labs recently posted quarterly revenue of $188 million, a 12% increase compared to the previous year. This growth was driven by strong retail performance and expanding wholesale operations. The company remains one of the top-selling brands in the U.S. cannabis market.

The company’s gross profit margin improved to 53%, reflecting better cost management and higher sales volumes. However, net income remains negative, with a reported loss of $9.8 million. The company is working on reducing operational expenses to improve profitability.

Cresco also maintains a solid cash position, with $85 million in cash reserves. This financial stability allows the company to invest in expansion and strategic acquisitions. As one of the leading MSOs in the U.S., Cresco remains a top stock to watch in the cannabis sector.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Investing in Cannabis: Strong Financials and Expansion Ahead

The cannabis industry is experiencing renewed interest as legalization efforts progress. Companies with strong market presence and efficient operations are best positioned for growth. Planet 13 Holdings, Glass House Brands, and Cresco Labs are three top stocks to watch in March 2025.

Each company has a unique business model and strong financials, making them attractive investment options. However, the cannabis market remains volatile, so investors should use technical analysis and risk management when considering these stocks. As the industry evolves, these companies could see significant growth in the coming months.

The post March 2025’s Top Cannabis Stocks: Key Players in the Growing Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization.

This article highlights three leading Canadian cannabis stocks to watch in March. Aurora Cannabis Inc. (ACB), Village Farms International Inc. (VFF), and SNDL Inc. are key players in the sector. Each company has carved out its niche and demonstrated growth potential. Investors should consider recent financial results, expansion plans, and market positioning before making decisions.

[Read More] 3 Marijuana Stocks To Keep On Your Radar 2025

Top Canadian Cannabis Stocks for March 2025: Who’s Leading the Market?

1. Aurora Cannabis Inc. (NASDAQ: ACB)
2. Village Farms International Inc. (NASDAQ: VFF)
3. SNDL Inc. (NASDAQ: SNDL)

Aurora Cannabis Inc. (ACB)

Aurora Cannabis is a well-known Canadian cannabis producer with a focus on medical and recreational markets. The company has a global presence, supplying cannabis to more than 20 countries. Although its U.S. exposure is limited, Aurora has made strategic investments in the hemp-derived CBD market. The company operates multiple production facilities across Canada, ensuring large-scale supply capabilities. It does not currently own or operate dispensaries in the U.S., but it remains positioned for potential market expansion.

Aurora continues to focus on the medical cannabis industry, which provides steady revenue streams. It has also been expanding its premium cannabis offerings, targeting higher-margin products. The company’s research and development efforts aim to improve product quality and innovation. Aurora’s strong brand portfolio gives it a competitive edge in the Canadian market.

Financials

In its latest financial report, Aurora showed signs of stabilization. The company reported net revenue of C$63 million, reflecting steady medical cannabis sales. Gross margins improved due to cost-cutting initiatives and operational efficiencies. Aurora also reduced its debt significantly, strengthening its financial position. Despite challenges in the recreational market, its medical cannabis business remains a strong performer.

The company has been working on achieving profitability by controlling expenses. It continues to focus on reducing costs while increasing high-margin product offerings. Aurora’s long-term strategy includes potential U.S. market entry if federal legalization occurs. Investors should monitor its cash flow management and operational improvements.

[Read More] Marijuana Penny Stocks with Big Potential in March 2025

Village Farms International Inc. (VFF)

Village Farms International is a Canadian agricultural company that has successfully transitioned into the cannabis industry. Originally a greenhouse vegetable grower, it has leveraged its expertise in controlled-environment farming to cultivate cannabis. Through its wholly owned subsidiary, Pure Sunfarms, the company has become one of Canada’s leading cannabis producers.

While Village Farms primarily operates in Canada, it has expanded its footprint in the U.S. through its hemp and CBD business. The company has partnerships and supply agreements in various states. Although it does not own dispensaries, its cannabis products are widely distributed through licensed retailers. Pure Sunfarms’ strong brand presence has helped it capture a significant Canadian market share.

The company’s ability to produce cannabis at a low cost gives it a competitive advantage. Its large-scale greenhouses allow for efficient cultivation, resulting in higher margins. This efficiency has helped Village Farms maintain a strong financial position in the industry.

Financials

Village Farms reported a net revenue of C$74.6 million in its latest earnings release. The company’s cannabis segment contributed C$36.7 million, reflecting steady growth in market demand. Pure Sunfarms remained a top-selling brand in Canada, driving strong sales performance. The company also improved its gross margin to 34%, showcasing cost efficiencies.

One of the biggest highlights was its positive adjusted EBITDA, indicating profitability in a challenging market. Village Farms continues to focus on expanding its cannabis portfolio while maintaining its core agricultural operations. The company remains optimistic about its U.S. expansion strategy, particularly in the CBD and hemp space.

Village Farms’ financial health is a key strength. It has maintained strong cash reserves, allowing flexibility for future investments. The company is positioned well for long-term success by focusing on cost control and innovation. Investors should watch for updates on potential U.S. legalization developments.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

SNDL Inc.

SNDL is one of Canada’s most diversified cannabis companies. It operates in both the retail and cultivation sectors, making it a unique player in the market. The company owns over 200 dispensaries across Canada under brands like Spiritleaf and Value Buds. This substantial retail presence provides SNDL with direct consumer access, helping it capture market share.

In addition to retail operations, SNDL is a major cannabis producer with large-scale cultivation facilities. The company focuses on premium and value-priced cannabis products, catering to a broad consumer base. It has expanded its portfolio through strategic acquisitions, including liquor retail businesses. This diversification reduces reliance on cannabis sales alone.

Although its U.S. presence is currently limited, SNDL has made investments that could facilitate future entry into the American market. The company remains focused on expanding its market share and enhancing product offerings.

Financials

SNDL’s latest financial report showed revenue of C$230.5 million, reflecting strong retail sales growth. The company’s cannabis segment contributed C$66.2 million, driven by increased product demand. It also reported a significant improvement in gross margins, benefiting from operational efficiencies.

One of the key highlights was SNDL’s positive adjusted EBITDA, marking a shift towards profitability. The company has been aggressively reducing costs and streamlining operations. Its diversified business model provides stability in an otherwise volatile industry.

SNDL also strengthened its balance sheet, reducing debt and increasing cash reserves. This financial discipline gives it flexibility for future expansion. The company continues to focus on optimizing its retail operations and product offerings. Investors should monitor the company’s progress in scaling operations while maintaining profitability.

Canada’s Top Cannabis Stocks for March 2025 Strong Picks for Investors

The Canadian cannabis sector remains a dynamic and evolving industry. Companies like Aurora Cannabis, Village Farms International, and SNDL continue to adapt to market conditions and position themselves for future growth. Each company has its unique strengths, from Aurora’s global medical cannabis presence to Village Farms’ low-cost production model and SNDL’s extensive retail network.

Financial performance is improving, with cost-cutting measures and operational efficiencies playing key roles. Investors should monitor revenue trends, profitability metrics, and expansion strategies. With potential U.S. legalization on the horizon, these companies could benefit from broader market opportunities.

As the cannabis industry continues to develop, selecting the right stocks requires careful analysis. Investors should consider financial stability, market positioning, and long-term growth potential. Watching how these companies navigate challenges will be crucial in assessing their future success.

The post Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to experience significant growth, thereby presenting investors with numerous opportunities. Notably, the legal cannabis market added approximately $115.2 billion to the U.S. economy in 2024. Furthermore, projections indicate that legal recreational cannabis sales in the United States are expected to reach nearly $58 billion by 2030. As a result, this robust expansion highlights the sector’s potential, ultimately making it an attractive consideration for investors.

Recent developments in U.S. cannabis legalization have further shaped the industry’s landscape. In New York, authorities have intensified efforts against unlicensed cannabis operations, closing 207 illegal stores. Simultaneously, the number of legal cannabis shops has risen to 307, generating substantial revenue. Additionally, major cannabis companies like Trulieve, Curaleaf, and Green Thumb have introduced hemp-based THC beverages, offering alternative revenue streams amid stalled federal cannabis reforms. These developments underscore the dynamic nature of the cannabis market and the importance of staying informed.

Investing In Top Pot Stocks

Investing in marijuana penny stocks can offer substantial returns but also carries inherent risks. Therefore, employing technical analysis and proper risk management strategies is crucial. Technical analysis involves examining price movements and trading volumes to identify patterns and trends, aiding in making informed investment decisions. Coupled with risk management techniques, such as setting stop-loss orders and diversifying portfolios, investors can better navigate the volatility associated with penny stocks. By staying informed about industry trends and utilizing analytical tools, investors can position themselves to capitalize on opportunities within the burgeoning cannabis sector.

The U.S. cannabis industry continues to flourish, offering investors a plethora of opportunities. This month, three marijuana stocks stand out: Planet 13 Holdings Inc. (PLNH), Cansortium Inc. (CNTMF), and Glass House Brands Inc. (GLASF). Moreover, each company has carved a unique niche in the market, making it worthy of attention.

[Read More] Here Is Why Marijuana Stocks Could See Some Upside This Month

Best U.S. Cannabis Stocks to Watch for the Next Market Rally in 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Cansortium Inc. (OTC: CNTMF)
3. Glass House Brands Inc. (OTC: GLASF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings Inc. is a vertically integrated cannabis company based in Nevada. It operates the world’s largest cannabis dispensary, the Planet 13 Cannabis Entertainment Complex, located just off the Las Vegas Strip. This flagship store spans 112,000 square feet and offers customers a unique, immersive experience. Beyond Nevada, Planet 13 has expanded its footprint with Santa Ana, California dispensaries and Waukegan, Illinois. The company also holds a medical marijuana treatment center license in Florida, allowing for statewide expansion. In total, Planet 13 operates 32 dispensaries across the United States.

In the third quarter of 2024, Planet 13 reported revenue of $32.2 million, a 29.7% increase from the same period in the previous year. The company’s gross profit rose by 50.8% year over year to $16.7 million, with a gross margin of 51.9%. Operating expenses decreased by 66.4% to $17.6 million, reflecting strategic cost management. However, the company recorded a net loss of $7.4 million, significantly improving from the $46.3 million loss in Q3 2023. Adjusted EBITDA reached $1.3 million, up from $0.2 million in the previous year, indicating enhanced operational efficiency.

[Read More] Top 3 Cannabis REITs for March 2025: Strong Dividends and Market Expansion

Cansortium Inc. (CNTMF)

Cansortium Inc., operating under the Fluent brand, is a vertically integrated cannabis company headquartered in Miami, Florida. The company focuses on producing and distributing premium medical cannabis products. Its operations are primarily concentrated in Florida, where it has established a strong presence. Cansortium also has operations in Texas, Pennsylvania, and Michigan, aiming to cater to a broad patient base. As of March 2025, the company operates 27 dispensaries in Florida, making it one of the prominent players in the state’s medical cannabis market.

In its latest financial report for the third quarter of 2024, Cansortium reported revenue of $22 million, marking a 15% increase compared to the same quarter in the previous year. The company’s gross profit was $12.5 million, with a gross margin of 56.8%. Operating expenses totaled $10 million, slightly higher than the previous year’s $9.5 million, primarily due to expansion efforts. Net income for the quarter was $1.2 million, a significant improvement from the net loss of $0.8 million reported in Q3 2023. Adjusted EBITDA stood at $5 million, up from $3.5 million in the same period last year, reflecting enhanced operational performance.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is a vertically integrated cannabis and hemp company based in California. The company cultivates, manufactures, and distributes cannabis products, focusing on sustainability and quality. Glass House operates several dispensaries across California, including locations in Santa Barbara, Los Angeles, and Berkeley. The company’s cultivation facilities are among the largest in the state, enabling it to produce cannabis at scale. As of March 2025, Glass House operates five dispensaries in California, with plans for further expansion.

In the third quarter of 2024, Glass House reported revenue of $28 million, a 20% increase from the same period in the previous year. The company’s gross profit was $14 million, with a gross margin of 50%. Operating expenses were $12 million, up from $10 million in Q3 2023, reflecting investments in expansion and marketing. The net loss for the quarter was $2 million, an improvement from the $5 million loss reported in the same period last year. Adjusted EBITDA was $6 million, up from $3 million in Q3 2023, indicating improved operational efficiency.

Marijuana Stocks to Watch Now as Legalization Efforts Gain Momentum

Planet 13 Holdings Inc., Cansortium Inc., and Glass House Brands Inc. are three notable U.S. marijuana stocks to watch this month. Each company has demonstrated growth and resilience in the evolving cannabis industry, making them worthy of consideration for investors seeking exposure to this burgeoning market.

The post Top Marijuana Stocks to Watch Now for Potential Growth in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand as more states legalize marijuana. In 2023, the industry generated over $34 billion in sales, with projections reaching $50 billion by 2028. Recently, federal lawmakers revisited discussions on banking reform, which could improve cannabis companies’ access to capital. Additionally, states like Florida and Pennsylvania are considering new recreational legalization measures, potentially boosting the market. Investors remain focused on companies with strong financials and strategic growth plans. However, stock prices remain volatile due to regulatory uncertainty. To navigate this sector, traders must watch price action and market trends carefully.

Using technical analysis is essential when trading marijuana stocks. Indicators like moving averages, support levels, and RSI can help identify entry and exit points. Additionally, proper risk management is necessary due to market volatility. Setting stop-loss orders and avoiding overexposure to single stocks can protect capital. As legalization momentum builds, strong companies with solid financials could see increased investor interest.

U.S. Marijuana Stocks as Legalization Advances

The U.S. cannabis industry continues to grow as more states legalize marijuana for medical and recreational use. Although the sector faces regulatory challenges, top companies are expanding operations and generating strong revenue. Investors are closely watching companies that dominate the market while maintaining steady financial growth.

Three major players—Trulieve Cannabis Corp. (TCNNF), Verano Holdings Corp. (VRNOF), and Green Thumb Industries Inc. (GTBIF)—stand out this month. These companies have built strong retail footprints across key states. They also continue to report solid earnings despite ongoing market fluctuations. Below, we will analyze each company’s market presence and latest financials.

[Read More] These Marijuana Stocks Could Make The Difference In Your Portfolio

3 Top U.S. Marijuana Stocks to Watch This February for Big Moves

1. Trulieve Cannabis Corp. (OTC: TCNNF)
2. Verano Holdings Corp. (OTC: VRNOF)
3. Green Thumb Industries Inc. (OTC: GTBIF)

Trulieve Cannabis Corp. (TCNNF)

Trulieve Cannabis Corp. is a leading multi-state operator (MSO) in the U.S. The company is best known for its strong presence in Florida. It operates over 180 dispensaries nationwide, with more than 120 stores in Florida alone. Trulieve has also expanded into other key markets, including Pennsylvania, Georgia, and Arizona. The company’s focus on vertical integration has allowed it to control production, distribution, and retail sales efficiently.

Recently, Trulieve has worked to expand beyond Florida, acquiring assets in strategic locations. Its growing presence in medical and recreational markets has positioned it as a key player in the industry. With a reputation for high-quality cannabis products and strong customer loyalty, Trulieve remains a dominant force in the sector.

Trulieve’s Latest Financials

Trulieve’s recent earnings report highlighted steady revenue growth despite challenges in the cannabis industry. The company generated over $280 million in revenue for the last quarter, maintaining consistent sales across key markets. Gross margins remained stable, reflecting Trulieve’s focus on cost management and efficiency.

However, the company reported a slight decline in profits due to rising operating expenses and market competition. Despite this, Trulieve continues to invest in long-term expansion strategies. It remains focused on acquiring licenses in new states and optimizing retail operations.

With a strong balance sheet and a dominant position in Florida, Trulieve remains a top stock to watch. If cannabis reform advances at the federal level, the company could see further growth opportunities.

[Read More] 2 Cannabis Stocks For Potential Market Movers This Year

Verano Holdings Corp. (VRNOF)

Verano Holdings Corp. is another major U.S. cannabis operator with a broad national footprint. The company operates over 135 dispensaries across multiple states, including Illinois, Florida, and New Jersey. Verano is well known for its premium cannabis brands and vertically integrated business model.

One of the company’s largest markets is Illinois, where it holds a strong retail presence. Additionally, it has been expanding aggressively in New Jersey, benefiting from the state’s growing recreational cannabis market. Verano’s dispensaries operate under the Zen Leaf and MÜV brands, offering high-quality cannabis products to consumers.

The company has been actively acquiring licenses and expanding cultivation facilities. By focusing on both medical and recreational markets, Verano has positioned itself for long-term success. It continues to be a top contender in the cannabis industry.

Verano’s Latest Financials

Verano recently reported quarterly revenue of $250 million, reflecting steady growth in key markets. The company has maintained strong profit margins despite regulatory and tax burdens in the cannabis industry. Additionally, Verano has managed to keep operating costs under control, improving its overall financial health.

While many cannabis companies struggle with cash flow, Verano has maintained a solid liquidity position. The company’s expansion into New Jersey and Pennsylvania has contributed to revenue growth. It has also focused on efficiency by streamlining production and retail operations.

Verano’s leadership remains optimistic about future federal cannabis reforms. If federal banking restrictions ease, the company could gain access to better financial services, improving its profitability. With strong market positioning and a focus on quality products, Verano remains a stock to watch.

[Read More] Mid-February Watchlist: Leading Cannabis REITs for Real Estate Growth

Green Thumb Industries Inc. (GTBIF)

Green Thumb Industries Inc. is one of the largest cannabis operators in the U.S. The company runs over 130 dispensaries across key states, including Illinois, Pennsylvania, and Nevada. Its Rise Dispensaries brand has built a strong reputation in both medical and recreational markets.

Illinois is one of Green Thumb’s most profitable markets, benefiting from strong cannabis sales and increasing demand. The company also has a significant presence in Nevada, Massachusetts, and Maryland, positioning itself for further expansion. Green Thumb has focused on maintaining a vertically integrated structure, controlling cultivation, production, and retail operations.

With a focus on innovation, Green Thumb continues to introduce new cannabis products. The company’s strategy has helped it remain competitive in a fast-growing industry. It remains a major player in the U.S. cannabis market.

Green Thumb’s Latest Financials

Green Thumb recently reported quarterly revenue exceeding $280 million, reflecting strong demand across its dispensaries. The company’s gross margins have remained high due to its efficient operations and strong brand presence. Additionally, Green Thumb reported a positive net income, a rare achievement in the cannabis industry.

Unlike many competitors, Green Thumb has maintained profitability in multiple quarters. This financial stability has attracted investors looking for strong cannabis stocks. The company has continued expanding into new markets while keeping operating costs in check.

Green Thumb also benefits from a diversified revenue stream. Its focus on branded products and wholesale distribution has helped sustain its financial performance. With potential federal cannabis reforms ahead, Green Thumb remains well-positioned for future growth.

[Read More] High-Potential Ancillary Cannabis Stocks to Watch in February 2025

U.S. Pot Stocks Positioned for Expansion

The U.S. cannabis industry continues to evolve, presenting both challenges and opportunities. Trulieve, Verano, and Green Thumb remain among the top cannabis companies to watch in February 2025. Each company has built a strong retail presence and continues to grow despite market fluctuations.

Their financial performance shows resilience, with steady revenue and cost management strategies in place. If federal reforms advance, these companies could see even greater expansion opportunities. Investors should keep a close eye on market developments and regulatory changes.

As the industry matures, well-established companies like Trulieve, Verano, and Green Thumb will likely lead the way. Their ability to navigate challenges while maintaining financial strength makes them stand out in cannabis stocks.

The post Best U.S. Cannabis Stocks to Watch in February: Key Players in the Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The growth of the cannabis industry is set to have a profound impact on marijuana stocks in 2025. With an increasing number of states and countries legalizing cannabis, the market is expanding rapidly. This has led to the potential of creating lucrative investment opportunities. Cannabis stocks trade with high levels of volatility. This has made it tough to gauge market patterns and trends as things can shift without warning. For some time many depend on the volatility to be able to make a profit.

For example, when there is a drop in trading a momentary volatile rise can moment to make some money. Before the pandemic, most marijuana stocks were able to see strong recoveries and consistent upward momentum. But that has long changed and a landscape of the market has been created. This does not mean that all is lost as there is still much to be done for the sector.

At any point, things can change and that’s the upside to volatility and speculation it turns in favor of shareholders. For instance, if the news on a regulatory issue gets out and it is positive and impactful enough it can help to trade. The better the news the bigger the impact and there is still a long road ahead. These marijuana stocks to watch below are a few examples of companies making headway in the sector. Which could be a good investment opportunity as well.

Top Marijuana Stock Picks 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Canopy Growth Corporation (NASDAQ:CGC)
3. Village Farms International, Inc. (NASDAQ:VFF)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Recently the company announced it has expanded its medical cannabis portfolio in Germany. Tilray’s new medical cannabis offerings in Germany include the introduction of additional product sizes for its top-selling medical cannabis extract As well as a new formulation aimed at addressing the diverse needs of patients and healthcare providers.

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products.

Which are mainly for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. On Feb 7th the company announced it has reported its Q3 2025 financial results.

Highlights And Keymentions

• Net revenue in Q3 FY2025 decreased 5% compared to the third quarter ended December 31, 2023
• Gross margin decreased by 400 basis points (“bps”) to 32% in Q3 FY2025 compared to Q3 FY2024.
• Adjusted EBITDA loss of $3MM in Q3 FY2025, representing a 61% improvement year-over-year.
• Operating loss from continuing operations was $24MM in Q3 FY2025, representing an improvement of 61% compared to Q3 FY2024.

[Read More] Mid-February Watchlist: Leading Cannabis REITs for Real Estate Growth

Village Farms International, Inc.

Village Farms International, Inc., together with its subsidiaries, produces, markets, and sells greenhouse-grown tomatoes, bell peppers, and cucumbers in North America.

During the first week of February, the company announced it had begun sales at the Leli Holland subsidiary in the Netherlands. Leli Holland holds one of 10 licenses to produce and distribute recreational cannabis in the regulated program in the Netherlands.

[Read More] High-Potential Ancillary Cannabis Stocks to Watch in February 2025

Words From The Company

Michael DeGiglio, President and Chief Executive Officer of Village Farms International commented, “Today’s news marks the culmination of nearly five years of work by our team to commercialize Leli’s operations, and we are thrilled to begin deliveries to Dutch coffeeshops and meet our previously-disclosed timeline to launch of sales”

The post Here Is How Marijuana Stocks Are Impact By The Cannabis Industry appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues expanding, creating opportunities for real estate investment trusts (REITs) that finance dispensaries and cultivation facilities. The legal cannabis market is projected to reach $41.5 billion by 2025, growing at a rapid pace. Currently, 38 states allow medical marijuana, while 24 states have legalized recreational use. This expansion fuels demand for real estate, making cannabis REITs essential for industry growth. Recent legalization efforts in Florida and Pennsylvania could further boost the market. However, federal cannabis reform remains uncertain, causing volatility in cannabis-related stocks. Investors must carefully analyze market conditions before making decisions.

Technical analysis helps identify optimal entry and exit points for cannabis REITs. Traders use moving averages, support levels, and volume trends to predict price movements. Risk management is also crucial, as cannabis stocks often experience sharp price swings. Setting stop-loss orders and diversifying investments can help protect capital. With strong demand for real estate and potential legalization news, top cannabis REITs remain attractive investments this week.

Fueling the Cannabis Industry’s Expansion

The cannabis industry continues to expand in the United States, making real estate investment trusts (REITs) crucial for its growth. These companies provide capital and property leasing solutions to cannabis businesses. As the demand for dispensaries and cultivation facilities increases, cannabis REITs remain essential. Investors looking for long-term opportunities should consider companies with solid financials and strong tenant relationships.

This month, three cannabis REITs stand out due to their market presence and growth potential. Innovative Industrial Properties, Inc. (IIPR) remains a dominant force in the sector. NewLake Capital Partners, Inc. (NLCP) offers diverse real estate holdings. Chicago Atlantic Real Estate Finance, Inc. (REFI) focuses on specialized lending in the cannabis space. Each company has a unique approach to navigating the complexities of cannabis real estate. Below is a closer look at these three top REITs to watch in February.

[Read More] High-Potential Ancillary Cannabis Stocks to Watch in February 2025

Best Cannabis REITs to Watch This Month for Long-Term Gains

1. Innovative Industrial Properties, Inc. (NYSE: IIPR)
2. NewLake Capital Partners, Inc. (OTC: NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI)

Innovative Industrial Properties, Inc. (IIPR)

Innovative Industrial Properties, Inc. (IIPR) is the leading cannabis-focused REIT in the U.S. The company specializes in acquiring and leasing industrial facilities to licensed cannabis operators. IIPR operates in over 19 states, making it one of the most geographically diverse cannabis REITs. Its portfolio consists of over 100 properties leased to major multi-state operators. These tenants include Cresco Labs, Green Thumb Industries, and Trulieve Cannabis.

The company provides long-term, triple-net leases, allowing it to generate steady revenue. IIPR’s strategy focuses on sale-leaseback transactions, giving cannabis operators access to capital. This approach helps businesses expand while ensuring IIPR’s long-term rental income. Its large presence across the country makes it a crucial real estate player in the cannabis sector. Investors watch IIPR closely due to its strong position in the industry.

IIPR reported strong financial results in its most recent earnings release. In its latest quarter, the company posted a total revenue of approximately $77 million. This represents a steady increase compared to previous quarters. The REIT maintains a high occupancy rate, with nearly all properties leased. Net income for the quarter reached over $40 million, showing strong profitability.

IIPR continues to offer high dividend yields, making it attractive to income-focused investors. The company’s cash flow remains strong due to its long-term lease agreements. Despite industry challenges, IIPR has managed to maintain stability. The company’s solid financials and strategic expansions make it a top cannabis REIT to watch in February.

[Read More] 3 Marijuana Stocks For Investors To Follow This Week

NewLake Capital Partners, Inc. (NLCP)

NewLake Capital Partners, Inc. (NLCP) is another major cannabis REIT with a growing national presence. The company provides real estate capital to state-licensed cannabis operators. NLCP owns a diversified portfolio of cultivation, processing, and retail properties. The REIT currently operates in 12 states, supporting both medical and recreational cannabis businesses. It leases properties to some of the largest cannabis operators in the U.S., including Curaleaf and Trulieve.

NLCP focuses on sale-leaseback transactions, offering operators liquidity while securing long-term rental income. Its properties are spread across key cannabis markets, ensuring revenue stability. The company continues expanding its portfolio by acquiring high-quality cannabis real estate. By working with experienced operators, NLCP reduces risk and maintains financial stability. Its growing property base positions it well for long-term industry expansion.

In its most recent earnings report, NLCP demonstrated strong financial health. The company posted total revenue of approximately $13 million for the quarter. This represents year-over-year growth as the REIT continues expanding its holdings. Net income reached over $7 million, showing a stable and profitable business model. The company maintains a high occupancy rate, with nearly all properties leased to well-established cannabis companies.

NLCP’s strong balance sheet allows it to invest in new properties and expand its footprint. The company also offers a competitive dividend yield, making it attractive to income investors. Despite the ongoing regulatory uncertainty in cannabis, NLCP remains financially sound. Its conservative investment approach ensures long-term growth potential. Investors looking for a stable cannabis REIT should keep an eye on NLCP this month.

[Read More] 3 Of The Best Marijuana Stocks For Your Stocks Market Watchlist

Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance, Inc. (REFI) specializes in lending to cannabis businesses. Unlike traditional REITs, REFI focuses on real estate-backed loans rather than direct property ownership. The company provides financing to licensed cannabis operators across the U.S. This lending model allows cannabis businesses to secure capital for expansion. REFI’s portfolio includes a mix of cultivation, processing, and retail properties.

The company operates in several key cannabis markets, including California, Florida, and Massachusetts. By providing loans to well-established cannabis operators, REFI ensures steady returns. Its real estate-backed lending model reduces risk while generating strong income. REFI’s unique approach makes it a standout among cannabis-focused REITs. The company’s strategy allows it to navigate regulatory challenges while maintaining profitability.

REFI’s latest financial results highlight its strong performance. The company reported total interest income of approximately $13 million in its latest quarter. This represents steady growth as cannabis businesses seek financing options. Net income for the quarter exceeded $8 million, reflecting strong profitability. The company maintains a diverse loan portfolio with high repayment rates.

REFI’s lending strategy provides flexibility compared to traditional cannabis REITs. The company benefits from strong demand for real estate-backed loans in the cannabis sector. REFI also offers an attractive dividend yield, making it appealing to income investors. With steady financials and a growing loan portfolio, REFI remains a top cannabis REIT to watch. Investors seeking a unique approach to cannabis real estate should consider REFI in February.

[Read More] Best Marijuana Penny Stocks to Watch in February 2025 as the Sector Heats Up

Top Cannabis REITs for Mid-February as Demand for Properties Grows

Cannabis REITs continue to play a vital role in the rapidly expanding marijuana industry. For example, companies like IIPR, NLCP, and REFI actively provide essential real estate financing solutions. Moreover, their long-term leases, sale-leaseback transactions, and lending strategies significantly support industry growth. However, despite ongoing regulatory challenges, these REITs continue to maintain strong financial performance.

For investors looking to gain exposure to the cannabis industry, these REITs should be carefully considered for their portfolios. Notably, IIPR remains the dominant player with a vast and growing property network. Meanwhile, NLCP offers diversification and stability through its strategically placed real estate holdings. At the same time, REFI provides a unique lending approach with potentially high returns. As a result, as the cannabis market continues to evolve, these REITs appear well-positioned for long-term success.

The post Mid-February Watchlist: Leading Cannabis REITs for Real Estate Growth appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, creating strong opportunities for ancillary companies that support dispensaries and cultivators. In 2024, legal cannabis sales in the U.S. exceeded $35 billion, with projections reaching over $40 billion by 2025. Ancillary businesses that provide technology, equipment, and services benefit from this rapid growth without facing the same legal challenges as plant-touching companies. Recently, federal legalization talks have gained momentum, with lawmakers pushing for banking reform and rescheduling cannabis. If these changes occur, more businesses could enter the market, boosting demand for ancillary services. Investors looking for exposure to the sector should watch these stocks closely.

When trading cannabis stocks, technical analysis and risk management are essential. Volatility remains high, making support and resistance levels key for identifying potential entry points. Additionally, traders should monitor volume trends and moving averages to gauge momentum. Setting stop-loss orders helps protect against sudden market swings. As legalization efforts advance, traders should stay updated on industry news. Changes in regulations often impact stock prices, creating both risks and opportunities.

As the cannabis industry expands, ancillary companies are playing a critical role. These businesses do not grow or sell cannabis directly. Instead, they provide essential services and infrastructure to dispensaries and growers. Ancillary stocks offer investors a way to gain exposure to the sector while avoiding legal restrictions tied to plant-touching businesses.

With U.S. cannabis sales projected to exceed $40 billion by 2025, companies supporting dispensaries and growers are expected to see strong demand. Additionally, federal legalization talks continue, which could drive further growth. Below are three top ancillary cannabis stocks to watch in February 2025.

[Read More] 3 Of The Best Marijuana Stocks For Your Stocks Market Watchlist

3 Ancillary Cannabis Stocks to Watch in February for Strong Returns

Leafly Holdings, Inc. (NASDAQ: LFLY)

WM Technology, Inc. (NASDAQ: MAPS)

GrowGeneration Corp. (NASDAQ: GRWG)

Leafly Holdings, Inc.

Leafly Holdings, Inc. is a well-known cannabis technology platform. The company operates one of the largest online cannabis marketplaces, helping consumers discover products and dispensaries. Its platform offers reviews, strain information, and purchasing options. This makes it a crucial tool for both consumers and dispensary owners.

The company has a strong presence across the U.S. It connects over 4,500 dispensaries with millions of customers each month. Leafly also provides advertising and data analytics services, helping dispensaries attract and retain customers. In states like California, Colorado, and Michigan, Leafly is a top choice for cannabis users seeking information on legal products.

Recently, Leafly has been expanding its business model. It now integrates directly with dispensary point-of-sale systems. This allows real-time product availability updates. As the cannabis market grows, Leafly continues to strengthen its role as a vital industry resource.

Leafly’s Latest Financials

Leafly’s most recent earnings report showed steady revenue growth. In its latest quarter, the company reported $11.3 million in revenue, marking a 7% year-over-year increase. This growth was driven by increased ad spending from dispensaries and product manufacturers.

However, the company continues to face challenges. Leafly reported a net loss of $4.8 million, mainly due to higher operating costs and investments in platform upgrades. Despite this, Leafly has been working to improve efficiency. The company has streamlined its workforce and optimized marketing expenses.

Cash reserves remain stable. Leafly ended the quarter with $21 million in cash and short-term investments. This gives it enough liquidity to fund operations while expanding its market reach. If ad revenues continue to grow, Leafly could move closer to profitability in the near future.

[Read More] Top U.S. Cannabis Stocks to Watch This Month: February 2025 Picks

WM Technology, Inc.

WM Technology, Inc., known as Weedmaps, is another major player in cannabis tech. It provides an online platform that connects consumers with dispensaries and delivery services. Weedmaps also offers software solutions that help dispensaries manage their businesses efficiently.

Weedmaps is widely used across the U.S., particularly in states with well-established cannabis markets. The platform lists over 5,000 dispensaries and serves millions of monthly users. In states like California, Nevada, and Arizona, Weedmaps plays a crucial role in the cannabis supply chain.

Beyond being a marketplace, Weedmaps offers business tools. Its software helps dispensaries handle inventory tracking, compliance, and customer engagement. This makes it a key partner for legal cannabis businesses looking to streamline operations. The company also provides advertising services, allowing dispensaries to boost visibility.

WM Technology’s Latest Financials

WM Technology recently posted $50.6 million in quarterly revenue, reflecting a 5% year-over-year decline. The decrease was attributed to lower ad spending from dispensaries facing economic pressures. However, the company remains profitable, with a net income of $3.2 million for the quarter.

The company has been focusing on cost control. Operating expenses have been reduced by 10% year-over-year, helping maintain profitability. Weedmaps also continues to invest in improving its platform. New features, such as AI-driven recommendations, have increased user engagement.

Despite short-term revenue challenges, Weedmaps has a strong cash position. The company reported $62 million in cash reserves, ensuring financial stability. With potential federal legalization on the horizon, Weedmaps could see an uptick in business as more dispensaries enter the market.

[Read More] Ancillary Cannabis Stocks to Watch in February: Strong Picks for 2025

GrowGeneration Corp.

GrowGeneration Corp. is one of the largest suppliers of hydroponic and cultivation equipment in the U.S. The company provides growers with lighting, nutrients, soil, and irrigation systems. As legal cannabis cultivation expands, GrowGeneration plays a crucial role in supplying the industry.

GrowGeneration currently operates over 60 retail locations across the U.S., with a strong presence in California, Colorado, and Oklahoma. These states have some of the highest cannabis production levels. The company also serves commercial cultivators, providing bulk equipment and consulting services.

In addition to retail stores, GrowGeneration operates an e-commerce platform. This allows growers to order supplies online with fast shipping. The company continues to expand, acquiring smaller hydroponic retailers to strengthen its market share.

GrowGeneration’s Latest Financials

GrowGeneration’s latest earnings report showed $65.7 million in quarterly revenue, representing a 4% year-over-year increase. The growth was driven by higher demand for cultivation supplies, particularly in newly legalized states.

However, the company reported a net loss of $2.5 million for the quarter. This was primarily due to supply chain challenges and rising operating costs. GrowGeneration has been working to address these issues by optimizing its distribution network.

Cash reserves remain healthy. The company ended the quarter with $78 million in cash, providing flexibility for future expansions. GrowGeneration also recently announced new partnerships with major cannabis cultivators. If demand for growing supplies remains strong, the company could see improved profitability in upcoming quarters.

Cannabis Stocks for February as Industry Demand Increases

Ancillary cannabis stocks provide unique investment opportunities. They support the industry without directly handling cannabis, making them more accessible to investors. Leafly, WM Technology, and GrowGeneration are three leading companies in this space. Each plays a key role in connecting consumers, supporting dispensaries, and supplying cultivators.

Despite some financial challenges, these companies remain strong industry players. With potential federal legalization and continued market expansion, ancillary cannabis stocks could see significant growth in 2025. Investors looking for exposure to the sector should keep a close watch on these companies in the coming months.

The post High-Potential Ancillary Cannabis Stocks to Watch in February 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues expanding despite recent market volatility. In 2023, legal marijuana sales surpassed $33.6 billion, and analysts project growth to $71 billion by 2030. Many marijuana penny stocks have gained momentum, attracting investors looking for high-reward opportunities. With increasing state-level legalization, companies are expanding operations to capture market share. Recently, Pennsylvania and Ohio made progress toward adult-use legalization, boosting investor optimism. These developments could accelerate revenue growth for multi-state operators and smaller cannabis companies. However, penny stocks remain highly volatile, requiring proper risk management. Investors should carefully analyze company fundamentals before making investment decisions.

Using technical analysis can help traders identify strong entry points. Key indicators, such as moving averages and support levels, provide insight into market trends. Many cannabis stocks remain oversold, creating potential buying opportunities. However, it is crucial to set stop-loss levels to minimize downside risk. As the market fluctuates, staying updated on industry news and legalization efforts remains essential for cannabis investors.

The cannabis sector continues to show potential despite market volatility. Many marijuana penny stocks have gained momentum, offering growth opportunities for investors. In particular, three companies saw notable gains last week: Ascend Wellness Holdings, Inc. (AAWH), The Cannabist Company Holdings Inc. (CBSTF), and Curaleaf Holdings, Inc. (CURLF). These companies have a strong presence in the U.S. cannabis market and have recently reported financial results that highlight their growth potential.

Investors are closely monitoring these stocks as they capitalize on expanding state markets. Each company operates dispensaries in key regions and benefits from increasing cannabis sales. Below, we will examine their market presence, financial performance, and what investors should expect moving forward.

[Read More] February 2025 Watchlist: Leading US Marijuana Stocks for Potential Gains

3 Hot Marijuana Penny Stocks for February 2025 as Legalization Momentum Grows

1. Ascend Wellness Holdings, Inc. (OTC: AAWH)
2. The Cannabist Company Holdings Inc. (OTC: CBSTF)
3. Curaleaf Holdings, Inc. (OTC: CURLF)

Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings is a multi-state cannabis operator focused on high-growth markets. The company has a strong presence in Illinois, Massachusetts, Michigan, New Jersey, and Ohio. It operates 32 dispensaries across these states, offering a range of premium cannabis products. Ascend focuses on high-quality flower, edibles, and vapes, catering to both medical and recreational consumers.

The company has continued expanding its footprint by acquiring more dispensary locations. Its New Jersey presence has grown significantly due to increasing adult-use cannabis demand. Additionally, Ascend has invested in vertical integration, ensuring product quality and supply chain efficiency. This strategy has helped it gain market share in competitive regions.

Recently, Ascend Wellness reported strong revenue growth in its latest financial results. The company’s Q3 2023 revenue reached $141.2 million, a 16% increase year-over-year. This growth was driven by higher sales in its core markets, especially in New Jersey and Illinois.

The company also reported an adjusted EBITDA of $34.6 million, showing improved operational efficiency. Gross margins remained strong, reaching 43% for the quarter, highlighting its ability to maintain profitability. Additionally, Ascend reduced its net losses, demonstrating financial improvement despite economic challenges.

Moving forward, the company plans to expand its dispensary count and improve product offerings. If cannabis legalization efforts continue to progress, Ascend could see even more growth opportunities in 2024. Investors remain optimistic about the company’s potential to gain market share in new and existing markets.

[Read More] 3 Major Marijuana Stocks With Upside Potential In The Stock Market

The Cannabist Company Holdings Inc.

The Cannabist Company, formerly known as Columbia Care, is a well-established cannabis operator. The company has a significant presence in over 14 U.S. states, including New York, New Jersey, Pennsylvania, and Florida. It operates 94 dispensaries, making it one of the largest cannabis retailers in the country.

The Cannabist focuses on both medical and recreational markets, adapting its strategy as laws evolve. The company has expanded its footprint in New York and New Jersey, two markets with rising demand for adult-use cannabis. Its dispensaries offer a variety of cannabis products, including flower, extracts, and edibles.

Recently, The Cannabist reported strong revenue growth despite broader market challenges. Q3 2023 revenue was $129 million, representing a 9% year-over-year increase. This growth was fueled by expanding operations in key markets and rising product demand.

The company also improved its gross margins to 48%, reflecting better cost controls and operational efficiency. Adjusted EBITDA came in at $19.4 million, showing steady financial improvement. The Cannabist has been working to reduce operating expenses and enhance profitability.

Additionally, the company has been restructuring its debt, improving its financial stability. It aims to increase dispensary openings and enhance its product lineup in competitive markets. The Cannabist remains a top contender in the industry, with significant expansion plans in New Jersey, New York, and Pennsylvania. Investors are watching closely as the company continues to strengthen its market position.

[Read More] Ancillary Cannabis Stocks to Watch in February: Strong Picks for 2025

Curaleaf Holdings, Inc.

Curaleaf is one of the largest multi-state cannabis operators in the U.S. It has a dominant presence in over 17 states, including Florida, Arizona, Pennsylvania, Illinois, and New Jersey. The company operates 150 dispensaries nationwide, serving both medical and recreational consumers.

Curaleaf is widely known for its diverse cannabis product offerings, including edibles, vapes, concentrates, and flower. It has continued expanding in key high-growth markets, particularly in the Northeast and Midwest. The company has also strengthened its European market presence, positioning itself for global expansion.

Recently, Curaleaf reported strong financial performance despite industry challenges. Q3 2023 revenue reached $338.6 million, reflecting a 5% year-over-year increase. New dispensary openings and rising consumer demand in Florida and New Jersey drove growth.

The company’s gross margins improved to 52%, showing better cost efficiency and pricing power. Additionally, Curaleaf’s adjusted EBITDA was $80.2 million, reflecting solid operational performance. The company has worked to reduce costs and improve profitability, strengthening its financial outlook.

Curaleaf is also expanding its product portfolio, focusing on innovation and premium product lines. The company continues to open new locations in strategic markets, further increasing its revenue potential. With the U.S. cannabis industry expected to grow, Curaleaf remains well-positioned for future success.

High-Growth Cannabis Penny Stocks to Watch in February

The cannabis sector remains volatile, but several marijuana penny stocks have shown significant upside recently. Ascend Wellness Holdings (AAWH), The Cannabist Company Holdings (CBSTF), and Curaleaf Holdings (CURLF) all reported strong revenue growth and solid financial performance. Each company is expanding its dispensary footprint and improving its profitability.

Investors looking for exposure to the cannabis industry may find opportunities in these stocks. As legalization efforts continue and demand increases, these companies could experience further growth. However, market risks remain, and investors should conduct proper research before making investment decisions.

With strong financials and expansion plans, these marijuana penny stocks could deliver further upside in the coming months. Keeping an eye on regulatory developments and industry trends will be crucial for understanding future growth potential.

The post Best Marijuana Penny Stocks to Watch in February 2025 as the Sector Heats Up appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The US cannabis industry continues to expand, with legal marijuana sales projected to reach $40 billion by 2025. Currently, 38 states have legalized medical cannabis, while 24 states allow recreational use. As legalization spreads, many companies are positioning themselves for long-term growth. Recent headlines indicate that federal rescheduling efforts are gaining momentum. The Department of Health and Human Services (HHS) has recommended reclassifying cannabis as a Schedule III substance, which could boost industry prospects. Investors are closely watching top marijuana stocks as they react to changing regulations.

When investing in cannabis stocks, using technical analysis and proper risk management is crucial. Many stocks experience high volatility, making tracking support and resistance levels essential. Investors often look for momentum indicators like the RSI and MACD to identify potential entry points. Setting stop-loss levels can help manage downside risks. As market conditions shift, traders should monitor volume trends and overall sector performance before making investment decisions.

Promising Picks for Growth

The US cannabis industry continues to grow despite regulatory hurdles. Many investors are looking for opportunities in top-performing marijuana stocks. As legalization efforts expand, several leading cannabis companies show strong growth potential.

In February, three US-based marijuana stocks stood out for their market presence and financial performance. Trulieve Cannabis Corp. (TCNNF), Cresco Labs Inc. (CRLBF), and Verano Holdings Corp. (VRNOF) are key players in the industry. These companies operate in major markets and have continued to expand.

Investors should watch these stocks closely as they navigate market fluctuations. Each company has a large retail footprint and a growing presence. Additionally, their financials provide insight into future performance. Below is a detailed breakdown of these three cannabis stocks.

[Read More] 3 Major Marijuana Stocks With Upside Potential In The Stock Market

Top US Cannabis Stocks for February 2025: Key Players in the Growing Market

1. Trulieve Cannabis Corp. (OTC: TCNNF)
2. Cresco Labs Inc. (OTC: CRLBF)
3. Verano Holdings Corp. (OTC: VRNOF)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. is a leading multi-state operator (MSO) in the US. The company has its largest presence in Florida, where it dominates the medical marijuana market. Trulieve operates over 180 dispensaries nationwide, with the majority located in Florida. The company has also expanded into Pennsylvania, Arizona, and Georgia, strengthening its national footprint.

Trulieve focuses on vertically integrated operations, controlling the supply chain from cultivation to retail. This approach has helped it maintain high margins and a strong market position. Its strategy includes expanding into new markets while reinforcing its leadership in Florida. The company’s focus on product quality and customer service makes it a top competitor in the industry.

Financially, Trulieve has faced some challenges but remains resilient. In its latest quarterly earnings report, the company reported revenue of $275 million, slightly lower than previous quarters. However, it remains profitable, with a strong cash flow.

The company has been reducing costs to improve efficiency. Its focus on streamlining operations and closing underperforming locations is helping stabilize margins. Despite some economic challenges, Trulieve is positioning itself for future growth. The company remains a strong player in the US cannabis market.

[Read More] Canadian Cannabis Market Update: Best Stocks to Track in February 2025

Cresco Labs Inc.

Cresco Labs is another leading US cannabis company with a significant market presence. It is well-known for its wholesale cannabis distribution and strong retail operations. The company operates over 60 dispensaries across key states, including Illinois, Pennsylvania, and Florida. It has built a solid reputation with its Sunnyside dispensary brand.

Cresco focuses on producing high-quality cannabis products. It has established itself as a top supplier to dispensaries nationwide. The company’s growth strategy includes expanding its wholesale network while strengthening its retail footprint. By investing in new markets, Cresco aims to remain competitive in the evolving cannabis industry.

In its latest quarterly financial report, Cresco reported revenue of approximately $190 million. While revenue remained stable, the company faced some profitability challenges. It has been working to improve operational efficiency and reduce costs.

Cresco is focusing on streamlining its business operations. It has adjusted its market strategy to maintain profitability. Despite some financial struggles, Cresco remains one of the strongest cannabis companies in the US. The company continues to adapt to market conditions and regulatory changes.

[Read More] Best Ancillary Cannabis Stocks for February: Strong Picks in Real Estate, Tech, and Equipment

Verano Holdings Corp.

Verano Holdings is a major cannabis operator with a strong presence in Illinois, Florida, and New Jersey. The company operates over 130 dispensaries and maintains a vertically integrated model. It controls the supply chain from cultivation to retail, allowing for better cost management and product quality.

Verano’s Zen Leaf and MÜV dispensaries are well-known among consumers. The company focuses on providing premium cannabis products while expanding its footprint in high-growth markets. Its focus on strategic acquisitions and organic growth has allowed it to scale rapidly.

Financially, Verano reported quarterly revenue of $240 million, showing steady growth. The company continues to expand while maintaining strong operational performance. Despite some industry headwinds, it remains profitable with a solid cash position.

Verano is optimizing its operations to boost efficiency. The company is focusing on cost-saving initiatives and strategic market expansion. Its ability to navigate regulatory challenges makes it a strong contender in the US cannabis market.

[Read More] February’s Top Marijuana Penny Stocks: High-Growth Potential in a Volatile Market

Marijuana Stocks to Watch This February: US Companies Leading the Industry

The US cannabis industry remains a dynamic market with strong growth potential. Trulieve Cannabis, Cresco Labs, and Verano Holdings are among the top marijuana stocks to watch in February. These companies continue to expand their operations despite market challenges.

Investors should monitor their financial performance and market strategies. Each of these companies has a solid retail presence and a focus on long-term growth. As legalization efforts progress, these stocks could provide significant opportunities for investors.

The post February 2025 Watchlist: Leading US Marijuana Stocks for Potential Gains appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..